Foley Partners Judith Waltz and Antoinette Konski authored an article that appeared in Genetic Engineering & Biotechnology News on July 1, 2011 titled “HHS Puts Stamp on Personalized Medicine.” The authors discuss the Department of Health and Human Services’ (HHS) influence on personalized medicine, stating that HHS has received legal and monetary support which should allow for alternative and creative approaches to better personalized healthcare. They add that HHS will also play a critical role in the regulation of direct-to-consumer marketing of genetic tests, noting that it is important for those in the personalized medicine sector to familiarize themselves with the multiple roles that HHS plays.
Author(s)
Related Insights
December 24, 2025
Health Care Law Today
Gender-Affirming Care: Multi‑State Lawsuit Challenges HHS Declaration
As previously discussed in Foley’s healthcarelawtoday, on December 18, 2025, the U.S. Department of Health & Human Services (HHS) held a press conference focused on what it defined as “sex rejection procedures” (SRPs), also known as gender-affirming care (GAC) for minors, and outlined next steps.
December 23, 2025
Energy Current
FERC Opens New Paths for Co-Located Loads in PJM: What Data Center and Power Generation Developers Need to Know
Key Takeaways FERC has ordered PJM to overhaul its tariff framework for co-located generation and large loads, finding existing rules…
December 23, 2025
Foley Viewpoints
The Rush to Exit: PE Firms Pick Up the Pace in 2025
Key Points: PE firms are moving to sell portfolio companies on an accelerated timeline in 2025 after years of much longer hold…